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We characterize the integrated response of a rat host to the liver fluke Fasciola hepatica using a
combination of 1H nuclearmagnetic resonance spectroscopic profiles (liver, kidney, intestine, brain,
spleen, plasma, urine, feces) and multiplex cytokine markers of systemic inflammation. Multi-
variate mathematical models were built to describe the main features of the infection at the systems
level. In addition to the expected modulation of hepatic choline and energy metabolism, we found
significant perturbations of the nucleotide balance in the brain, together with increased plasma IL-
13, suggesting a shift toward modulation of immune reactions to minimize inflammatory damage,
which may favor the co-existence of the parasite in the host. Subsequent analysis of brain extracts
from other trematode infection models (i.e. Schistosomamansoni, and Echinostoma caproni) did not
elicit a change in neural nucleotide levels, indicating that the neural effects of F. hepatica infection
are specific. We propose that the topographically extended response to invasion of the host as
characterized by the modulated global metabolic phenotype is stratified across several bio-
organizational levels and reflects the direct manipulation of host–nucleotide balance.
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Introduction
Fascioliasis is a re-emerging zoonotic disease caused by two
liver fluke species, Fasciola hepatica and F. gigantica. As many
as 17 million people might be infected with Fasciola spp.
(Keiser and Utzinger, 2009) and the disease is of considerable
economic and public health importance. At present, tricla-
bendazole is the only drug available for treatment of infected
human beings and livestock and worryingly, parasite resis-
tance to triclabendazole is already widespread in farm animals
(Fairweather, 2009). Hence, a deeper understanding of the
biology of this parasite is warranted to uncover novel
therapeutic targets. Fundamental investigations in well-
controlled host–parasite models hold promise for recovery of
metabolic biomarkers, at different bio-organizational levels.
This may promote the mechanistic understanding of the host
response to infection at the systems level with a view to
identifying drug targets.
The regulation of anymammalian system is such that events
originating in a discrete tissue or organ can trigger a cascade of
consequent events throughout the host system as the host
attempts to maintain homeostatic equilibrium (Lederberg,
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2000; Nicholson et al, 2002). Thus, the effects of a parasitic
infection are rarely confined to a single target tissue; instead a
network of molecular events can generally be detected
throughout the host system. Top-down systems biology driven
by metabolic phenotyping and metabonomics (Nicholson
et al, 1999; Holmes et al, 2008a; Li et al, 2008a, b; Tsang
et al, 2009) has been shown to be a useful tool for studying
host–parasite (Saric et al, 2008;Wang et al, 2008; Li et al, 2009)
and host–symbiont interactions (Nicholson et al, 2005; Martin
et al, 2007; Holmes et al, 2008b), and it is clear that any
transgenomic interaction can only be studied in vivo, as the
effects of microbial or parasitic modulations are panorganis-
mal (Wang et al, 2008; Saric et al, 2009).
In this study, we characterize and interpret the system-wide
effect of F. hepatica in the rat, using a metabolic profiling
strategy to develop mechanistic hypotheses. A multilevel
statistical approach was applied to the analysis of 1H nuclear
magnetic resonance (NMR) spectroscopy-generated data to
obtain an integrative profile of the global response of the host
based on differential metabolic, immunological, and bio-
metric responses across multiple tissues. We report novel
findings regarding the effect of F. hepatica on the neural
metabolite profile of the rat and show metabolic connections
between the liver, gut, and brain, which we compare with the
metabolic effects elicited by two separately assessed trematode
infections, namely Schistosoma mansoni and Echinostoma
caproni in a mouse model. Although F. hepatica-induced liver
damage has been described in detail before (Lim et al, 2007;
Marcos et al, 2008), no direct association with the central
nervous system has been found in the extant literature. The
findings from this study expose a potential mechanism of
parasite-induced immunemodulation and exemplify the value
of top-down systems approaches based on metabolic profiling
for recovering mechanistic information from a system without
a priori knowledge.
Results and discussion
Parasite burden, physiological monitoring,
and histology
Patent infection of rats with F. hepatica resulted in a mean
parasite burden of 5.5 (range¼2–10; s.d.¼2.6) on day 77
postinfection and a significant reduction of the mean packed
cell volume (PCV) at day 71 postinfection (uninfected control
rats: mean¼50.8%, s.d.¼2.8%; infected: mean¼42.0%, s.d.¼
3.8%). The mean bodyweight did not significantly differ
between infected and uninfected rats at any of the investigated
time points. Clear evidence of hepatic necrosis was found in
F. hepatica-infected rats (Supplementary Figure S1) together
with follicular hyperplasia of splenic white pulp and interstitial
lymphoplasmocytic inflammatory infiltrates in the kidney.
Multivariate statistical modeling of F. hepatica
infection
Assignment of metabolic components in the tissues and
biofluid profiles for both uninfected and infected rats were
made on the basis of extant literature (Coen et al, 2003; Holmes
et al, 2006; Beckonert et al, 2007; Li et al, 2009; Saric et al,
2009; Tsang et al, 2009), and in the case of the brain extract
spectra, from addition of authentic standards (assignments
provided in Supplementary Figure S2; Supplementary
Table SI).
The metabolic changes in the rat caused by patent infection
with F. hepatica were modeled separately for each biological
matrix through principal component analysis (PCA) and
projection to latent structure discriminant analysis (PLS-DA).
In brief, themetabolic profiles of F. hepatica-infected rats could
be differentiated from those of uninfected control rats through
PCA for all assessed biological compartments except the ileum
and the renal medulla. A list of important infection-discrimi-
natory metabolites is given in Table I together with the P-
values, validated by permutation testing, Figure 1.
Consistent changes in lipid metabolism, including elevated
choline and/or choline derivatives such as betaine, phospho-
choline, and glycerophosphocholine (GPC) occurred through-
out most tissues (Figure 1; Table I). This indicates a generally
increased usage of choline-derived metabolites that can be
further converted to phosphocholine (Zeisel et al, 2003; Li and
Vance, 2008), a basic component of membrane anabolism, or
used for the production of polyunsaturated fatty acids such as
arachidonic acid, which gives rise to pro-inflammatory
eicosanoic mediators (Calder, 2008, 2009). Prostaglandins,
for instance, exert multiple pro-inflammatory effects, such
as chemotaxis of neutrophils, which are typically the
first infiltrating cells at sites of tissue damage. Evidence of
inflammatory infiltrates was detected in the histological
and metabolic profiles of the liver, spleen, and kidney
(Supplementary Figure S1) and inflammation was implicated
biochemically in the colon and plasma. Increased
plasma intensities of O- and N-acetyl glycoprotein signals
were noted in F. hepatica-infected rats. Increased concentra-
tions of acetylated glycoproteins have been earlier identified
in Trichinella spiralis- and Trypanosoma brucei brucei-infected
mice (Martin et al, 2006; Wang et al, 2008) as inflammatory
markers and include acute phase reaction proteins, such
as a1 acid glycoprotein, haptoglobin, and transferrin,
which are produced in the liver and which show markedly
increased serum levels during such systemic responses to
inflammation (Schreiber et al, 1982; Bell et al, 1987a, b)
(Figure 1; Table I).
Other features of F. hepatica infection were specific to a
single biological compartment; for example hippurate, which
is only observed in the urine, was found to be decreased in
infected rats, reflecting a parasite-induced disturbance of the
gut-microbial composition or activity (Nicholls et al, 2003; Li
et al, 2008a, b). The liver, spleen and plasma showed the
greatest changes at the low molecular weight level, consistent
with the direct damage caused by the migrating larvae of F.
hepatica during the acute stage of an infection in the hepatic
tissue and the immunological activity in the spleen (Supple-
mentary Figure S1). The proliferation of B cells in the spleen
primary follicles as response to blood-borne antigens uses
amino acids and lipid fractions for the new cellular membrane
bilayers and organelles andmay account for themajor changes
in the metabolic profile of the spleen, and perhaps in other
tissue compartments. The depletion in hepatic glucose is more
likely to be related to the direct damage of the energy stores
and is consistent with elevated glucose levels in plasma.
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One of the strongest effects of infection with F. hepatica
manifested in the neurochemical profiles, further highlighting
the ability of the parasite to impact on remote tissue. Clear
visual separation of the infected and uninfected animals
was achieved in the PCA and PLS-DA scores plots (Figure 2A
and B) of the neural profiles, with a model predictivity (Q2Y)
of 0.46. The pattern of differentiating metabolites in the
neurochemical profiles as extracted from the orthogonal
PLS-DA (O-PLS-DA) coefficients was composed of a signif-
icant increase in the relative levels of inosine, tyrosine, and
phenylalanine. Conversely, the relative tissue concentrations
of GPC, succinate, inosine mono-, di-, and triphosphate,
adenosine, and adenosine mono-, di-, and triphosphate
were lower in the brains of infected animals (Figure 2C
and D).
Secretion of nucleotide-degrading enzymes occurs in a
variety of ecto- and endoparasitic organisms, such as ticks,
blood sucking insects, and helminths and serves the primary
purpose of minimizing immune reactions in the host organism
to prolong their survival (Parshad and Guraya, 1977; Ribeiro
and Francischetti, 2003). For example, adenosine deaminase
and 50-nucleotidase have been found in secretory channels of
T. spiralis and F. gigantica (Gounaris, 2002; Ali, 2008). The
former catalyzes the intracellular conversion of adenosine to
inosine, whereas the latter hydrolyzes inosinemonophosphate
(Figure 2E).
We observed a substantial shift of adenosine and phos-
phorylated nucleotides to inosine in the host brain, which
indicates an attenuated inflammatory response and may be
suggestive that F. hepatica, similarly to F. gigantica, secretes
nucleotide-degrading enzymes. Both inosine and adenosine
induce mast cell degranulation, an event that has a central
function in localized inflammatory response, an important
mediator of type I hypersensitivity reactions, with adenosine
being the more potent activator (Marquardt et al, 1978;
Tilley et al, 2000). Furthermore, inosine, which was believed
to be inert for a long time, has been proven to effectively
suppress pro-inflammatory cytokines such as IFN-g,
TNF-a, and IL-12 (Hasko et al, 2000, 2004; Mabley et al,
2003) in vitro and in vivo.
We assessed the concentrations of selected plasma cyto-
kines and found the levels of both IL-13 and IL-5 to be
significantly higher in F. hepatica-infected rats compared with
the control group on day 22 postinfection. IL-13 maintained a
significant increase on day 43 postinfection (Figure 2E). An
enhanced Th2 immune response such as that suggested by the
increase in both IL-5 and IL-13 would serve to counteract
mechanisms of inflammation. IL-13 is also an important
direct negative regulator of inflammatory cytokines in macro-
phages (Minty et al, 1993). Minimization of such an intense
immune reaction, and hence prolongation of the period
in which the parasite can remain undetected by the host at
earlier stages of infection, is clearly beneficial for the survival
of the worms.
Comparison of the systemic effects of F. hepatica
with S. mansoni and E. caproni
To ascertain the specificity of the global metabolic response of
the rat to F. hepatica across different tissue compartments,
particularly with respect to the observed modulation of the
neural nucleotide balance, two further rodent-trematode
models were compared, namely S. mansoni and E. caproni,
in a murine host. Both trematodes induced a biochemical
response across a range of biological compartments, but
whereas S. mansoni caused pathology in the spleen and liver
(Li et al, 2009), no overt necrosis was found in any tissue after
E. caproni infection (Saric et al, 2009). At a global level,
E. caproni infection was predominantly characterized by
Table I Candidate biomarkers extracted through O-PLS-DA of F. hepatica-infected and uninfected rats within selected tissue compartments
pl, plasma; ur, urine; fw, fecal water; li, liver; sp, spleen; rc, renal cortex; je, jejenum; co, colon; red: relatively increased; blue: decreased levels caused by infectionwith
F. hepatica; *o0.001.
Corresponding P-values are listed.
Systemic metabolic impact of F. hepatica in the rat
J Saric et al
& 2010 EMBO and Macmillan Publishers Limited Molecular Systems Biology 2010 3
malabsorption of amino acids, which manifested predomi-
nantly in the biochemical profiles of the small intestine and
liver. Altered amino-acid levels and energy metabolism were
also a core signature of S. mansoni infection with disturbed
levels of choline-containing membrane components in the
liver and intestinal tissues.
As the altered neural nucleotide signature was one of the
strongest metabolic responses in rats infected with F. hepatica,
we directly compared the metabolic profiles of brain extracts
with those from S. mansoni and E. caproni in the mouse.
S. mansoni infection induced obvious changes in the meta-
bolic composition of the host brain, as indicated by the PCA
and PLS-DA scores plots (Supplementary Figure S3), with the
PLS-DA model indicating a predictive value (Q2Y) of 0.61.
Infection with S. mansoni was characterized by higher levels
of glutamine, but lower concentrations of g-aminobutyric
acid (GABA), choline, phosphocholine, and scyllo-inositol
(Supplementary Figure S3C). The E. caproni-infected animals
could not be statistically differentiated from the correspond-
ing control group based on the brain extract spectra
(Q2Y¼0.21, data not shown), indicating that the in-
fection did not systematically alter the brain biochemistry of
the host.
Although both S. mansoni and F. hepatica induced a marked
perturbation of the neurochemical profiles in their host
animals, the patterns of differentiating metabolites were
distinct for these two trematode-rodent models, with the
exception of the common effect of decreasing concentrations
of lipid degradation products, such as choline, phospho-
choline, and GPC, all of which have a function in cell
membrane formation. In contrast to the perturbed immuno-
logical function suggested by the altered nucleotide levels in
the brains of F. hepatica-infected animals, modulation of the
neural metabolite profile by S. mansoni infection suggested
the dominant effect related to the neurotransmitters, as
supported by depleted levels of GABA and increased tissue
concentrations of glutamine, which is a substrate for both
excitatory and inhibitory neurotransmitters, including GABA.
However, as neural GABA decreased in infected animals, the
increased concentrations of glutamine are more likely to be indi-
cative of a detoxification process. Compensatory locations for
ammonium detoxification are muscle cells and the brain, com-
bining ammonia and glutamate to glutamine (Kreis et al, 1991;
Olde Damink et al, 2002), which could also contribute to the
relatively higher levels of glutamine in the brain extracts of S.
mansoni-infected mice documented in the current investigation.
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Systems impact of the modulation of the neural
metabolic phenotype of F. hepatica infection:
multivariate modeling and integration of
physiological compartments
Metabolic correlates of the six important discriminatory
spectral regions containing inosine, GPC, succinate, tyrosine,
phenylalanine, and the overlapped regions containing
adenosine and the phosphorylated nucleotides in the brain
tissue of F. hepatica-infected rats were identified in each of the
other tissue or biofluid matrices. Sequential correlations
between the integrated-discriminatory signals in the brain
spectra tissue were made with the whole spectra from each
tissue and with the spectra from biofluids obtained at day 71
postinfection (Figure 3; Supplementary Table SII). Here,
univariate correlation of single signals was preferred
over a multivariate approach to maximize information
recovery and to infer direct inter-compartmental links between
the metabolites. A comprehensive list of compartment-specific
correlations with the neural metabolites is provided in
Supplementary Table SII. The liver, urine, and spleen showed
the highest number of components correlatedwith the selected
brain metabolites. The high degree of correlation between the
metabolic markers in the brain and the liver spectra across
the tissue compartments (Figure 3A) may simply relate to the
magnitude of spectral changes in both organs and does
not necessarily imply any causal relationships between
metabolites. The gross changes in the hepatic metabolite
profile are reflective of direct mechanical damage of the liver
tissue by the migration and feeding of the juvenile fluke,
whereas the effect of the parasite on remote organs such as the
brain is more difficult to rationalize. Hepatic dysfunction in
F. hepatica infection is known to result in increased circulating
toxins, such as ammonia, thiols, and phenols (Zaki et al,
1983), which are typically released after hepatic failure,
because of reduced ability to degrade aromatic amino acids
and ammonia. Animals infected with F. hepatica showed
increased neural concentrations of phenylalanine and tyro-
sine. Indeed, it has been shown that hepatic failure induces an
increased passive permeability of the blood–brain barrier for
several substances, among which phenylalanine and tyrosine
were found to increase up to 30% in the host brain (Zaki et al,
1984).
A recurrent theme across multiple levels of this host–parasite
system was the inflammatory response, which manifested at
both the level of structural damage and that of the metabolite
signature. The increased signal intensities of plasma acetyl
glycoprotein fragments were statistically associated with all
six cerebral markers of infection underscoring the presence
and global effect of a strong infection-induced inflammatory
response (Figure 3B; Supplementary Table SII). Interestingly, a
shift has been observed in the brain nucleotides inosine and
adenosine in favor of inosine, which has been shown to have
anti-inflammatory effects at the posttranscriptional level
(Hasko et al, 2000), including suppression of pro-inflamma-
tory cytokines (e.g. IFN-g and TNF-a) and minimizing
macrophage-mediated mechanisms of inflammation (Hasko
et al, 2000, 2004; Liaudet et al, 2002). This shift may be directly
induced by nucleotide-degrading secretory enzymes of
F. hepatica. Significant direct correlations between the selected
neural indices of F. hepatica infection and compounds
involved in lipid metabolism were detected.
In addition to the correlations driven by the liver pathology,
direct metabolic interactions such as plasma glucose being
anti-correlated with brain succinate and 2-ketoglutarate,
suggestive of an interaction through glycolysis and the
tricarboxylic acid cycle, were found. Another example of such
co-variation is the inverse correlation between cerebral
tyrosine and urinary hippurate, deriving from gut-microbial/
mammalian co-metabolism. Direct alteration of urinary
metabolite signatures through gut-microbial species seems to
be a common feature of many host–parasite models
(Martin et al, 2006; Li et al, 2008a; Saric et al, 2008; Wang
et al, 2008). Here, the negative correlations of cerebral
adenosine with urinary dimethylglycine and the bile acids,
which are co-metabolized by gut microbiota, strengthens the
notion of a bidirectional communication between gut and
brain (gut–brain axis). This leads to the hypothesis
that nucleotide-initiated immunoactivity has a function in
the changed gut-microbial dynamics observed in parasitic
infections.
In conclusion, we have characterized the global metabolic
phenotype of a host–parasite system and have shown a clear
effect of a trematode infection on the biochemical composition
of the host brain using ametabolic profiling strategy to develop
and pursue hypotheses relating to the observed neurochemical
changes in the rat. F. hepatica induced a focussed response,
primarily associated with the hypothesized worm-induced
shift from adenosine toward inosine and the subsequent
induction of anti-inflammatory cytokines. The coherence
of the histological, metabolic, and cytokine data further
facilitated elucidation of general and specific metabolic events
and provided a means of probing inter-compartmental co-
variation of metabolites. Thus, the application of a top-down
systems approach has been shown to be of value in driving the
articulation of novelmechanistic hypotheses relating to parasitic
invasion and has wide application in molecular parasitology.
Materials and methods
F. hepatica-rat model and experimental design
Experimental procedures were carried out at the Swiss Tropical and
Public Health Institute (Swiss TPH; Basel, Switzerland), adhering to
local and national guidelines of animal welfare (permission no. 2070
and 2081). A total of 24 Wistar female rats were purchased from RCC
(Itingen, Switzerland) and kept under environmentally controlled
conditions (temperature: 251C; relative humidity: 60–70%; light/dark
cycle: 12/12 h). Rats were acclimatized for 1 week and all animals had
free access to commercially available rodent diet obtained from Nafag
(Gossau, Switzerland) and community tap water.
Rats were individually marked and group housed with four animals
per cage. Twelve rats were orally infected with 20–25 F. hepatica
metacercariae each (Cullompton isolate) obtained from Mr G Graham
(Addleston, UK). The remaining 12 rats were left uninfected and
served as controls.
The body weight of each animal was measured throughout the
experiment. On day 1 pre-infection and days 1, 4, 8, 15, 22, 28, 36, 43,
57, and 71 postinfection, urine and feces were collected into Petri
dishes by rubbing the abdomen of the rats gently. Approximately 50ml
of blood was collected from the tail tips collected into hematocrit
capillaries (Sodium [Na] heparin coated) and spun at 10 500 g for
4min. The PCV was calculated and expressed as a percentage of the
plasma ratio to red blood cells (Li et al, 2008a).
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All animals were euthanized on day 77 postinfection using CO2,
and the worm burden was determined in each infected animal by
removing adult flukes from the livers and bile ducts on dissection.
The whole brains of rats, regardless of their infection status, were
removed on dissection and the left hemispheres were transferred into
cryo-tubes, snap frozen in liquid nitrogen and stored at801C pending
1H NMR spectroscopic data acquisition. In addition, the left lateral
lobe of the liver, the left kidney, spleen, and three parts of the
intestine (colon, ileum, and jejunum) were removed and stored in the
same manner as the brain for 1H NMR spectroscopic data acquisition.
The right brain hemispheres, the right kidney, and parts of the
spleen, liver, and intestines were transferred into separate Eppendorf
tubes containing 4% buffered formalin for subsequent histological
examination.
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Methodology relating to the S. mansoni- and E. caproni-mouse
models has been described earlier (Saric et al, 2008, 2009; Li et al,
2009) and followed a similar protocol to that described for F. hepatica
infection in the rat.
Sample preparation for 1H NMR spectroscopy
Each brain sample was placed in a mortar, mashed using a 1ml
mixture of H2O and acetonitrile (1:1, v:v) and transferred into a glass
tube. Another 2ml of the solvent mixture was used to rinse the mortar
twice and transferred into the same glass tube. The brain homogenate
was centrifuged for 6min at 10 000 g. The supernatant was collected
into a new glass vial, evaporated overnight and lyophilized. The
resultant dry mass was resuspended into 0.55ml of D2O until
completely dissolved and transferred into a 5mm-outer-diameter
NMR tube for subsequent analyses. Urine, plasma, and fecal pellets
were prepared for conventional high-resolution 1H NMR data
acquisition as described earlier (Saric et al, 2008), whereas tissue
metabolic fingerprints were acquired through magic angle spinning
(MAS) 1H NMR (Saric et al, 2009).
The extraction protocol for the S. mansoni-mouse model was
slightly extended to gain additional information regarding potential
changes in the lipid metabolic profile, as a pharmacological interven-
tion was involved in the original study protocol. Each brain sample
obtained from mice infected with S. mansoni and the corresponding
uninfected control mice was transferred into a 2ml Eppendorf tube
containing a metal bead, 0.75ml of water, and 0.75ml of methanol.
The Eppendorf tubewas placed in the tissue lyser and shaken for 5min
at the speed of 22Hz. The resulting brain homogenate was transferred
into a glass tube. A further 0.75ml of each liquid was used to rinse the
Eppendorf tube and transferred into the same glass tube. A total of
1.5ml of chloroform was added into the mixture and centrifuged at
2500 g for 30min. The aqueous and the chloroform phases were
transferred into a new glass tube each and both were left to evaporate
overnight and lyophilized. Before 1H NMR analysis, the powder
obtained from the aqueous phase was dissolved in 0.55ml phosphate
buffer (D2O:H2O¼9:1, v:v, 0.01% of sodium 3-(trimethylsilyl) propionate-
2,2,3,3-d4 ([TSP)], pH¼7.4), whereas the dry mass of the chloroform
fraction was dissolved in deuterated chloroform (CDCl3).
Acquisition of 1H NMR spectral data
All 1H NMR spectra from rat and mouse brain extracts, urine, plasma,
and fecal water were recorded on a Bruker Avance 600 NMR
spectrometer (Bruker; Rheinstetten, Germany), operating at
600.13MHz for proton frequency. A 5-mm triple resonance probe
with inverse detection for proton frequency was used (Bruker), using a
standard one-dimensional NMR experiment with pulse sequence
(recycle delay (RD)-901-t1-901-tm-901-acquisition time). Optimal water
suppression was achieved by irradiating the water frequency during
the RD set to 2 s and the mixing time of 100ms. The 901 pulse length
was adjusted to 10.62ms for the brain extracts of both the F. hepatica rat
and the E. caproni-mouse models and 13.5ms for the S. mansoni-
mouse model. A total of 128 scans were acquired for each sample into
32k data points using a spectral width of 20 p.p.m. All free induction
decays were multiplied by an exponential function equivalent to a
0.3Hz line-broadening factor before Fourier transformation. Liver,
spleen, kidney, and intestinal samples were acquired by an MASm
probe, an NMR semi-solid state method using the parameters
described elsewhere (Saric et al, 2009).
Assignments of the spectral peaks were made from the literature
(Nicholson et al, 1995; Coen et al, 2003; Li et al, 2008a, 2009; Saric
et al, 2008) and confirmed through statistical total correlation
spectroscopy (STOCSY) (Cloarec et al, 2005), and through standard
two-dimensional NMR experiments conducted on selected samples,
including correlation spectroscopy (Ernst et al, 1986), total correlation
spectroscopy (Bax and Davies, 1985), and J-resolved NMR spectro-
scopy (Foxall et al, 1993). For selected brain samples, high-
performance liquid chromatography (HPLC) was performed to isolate
chemical components relating to unidentified-discriminatory metabo-
lites with spectral regions at chemical shifts of d 6.15 (doublet), d 8.60
(singlet), d 8.27 (singlet), and d 4.02 (multiplet). For this purpose,
fractionswere separated using an Agilent 1100HPLCwith Eclipse XDB-
C18 column, 5mm, 4.6150mm (Agilent), attached to an Esquire
6000 mass spectrometer (MS; Bruker; Rheinstetten, Germany). An
aliquot of 100ml of brain extract was injected at a flow rate of 1ml/min
and signals were detected byUVat 214nm and byMS in positivemode.
A gradient of 98%water to 2%acetonitrilewas used for the first 25min
and a standard gradient sequence was applied for the remaining
25min. Fractions were collected over the first 8min and then
lyophilized and resuspended in D2O for NMR analysis. Inosine,
inosine monophosphate, inosine diphosphate, inosine triphosphate,
adenosine, adenosine monophosphate, adenosine diphosphate, and
adenosine triphosphatewere confirmed by adding authentic standards
purchased from Sigma Aldrich (Gilingham; Dorset, UK).
Data processing and analysis
The raw spectra were processed with an in-house developed MATLAB
script to reduce phase and baseline distortions and manually
calibrated to the lactate CH3 signal at d 1.33 (spectra of brain extracts,
plasma, and tissue) or automatically to sodium 3-(trimethylsilyl)
[2,2,3,3-2H4] propionate (TSP) at a spectral position d 0.00 (urine and
fecal water). The region containing the residual water resonance was
removed to avoid any interferencewith the analysis (i.e. d 4.55–5.40 in
brain extracts, d 4.2–8.0 in plasma, d 4.63–5.15 in fecal extracts, d
4.23–5.32 in urine, and a similar region ofBd 4.7–5.2 was removed in
each tissue spectral dataset). Before statistical analysis, probabilistic
quotient normalizationwas applied to all spectra and a peak alignment
script was implemented in MATLAB to minimize chemical shift
variation (Veselkov et al, 2009).
In a first step, PCAwas applied to the processed spectral data to gain
an overview of the degree of differentiation between infected and
uninfected animals or inherent groupings in each tissue and biofluid
spectral dataset (Eriksson et al, 2001). PCA reduces the multivariate
data to a lower-dimensionality scores plot, without requiring any
earlier class information and delivers a snapshot of the similarity
between observations (i.e. brain spectra) based on the linear
combination of the spectral components. In a second step, PLS-DA
was applied, as a supervisedmethod,which uses earlier information of
class membership, and hence optimizes separation (Eriksson et al,
2001) and extraction of biomarkers associated with the infection.
O-PLS-DA is a further development of PLS-DA applied for optimal
recovery of biomarkers (Trygg andWold, 2002), and removes systematic
variation unrelated to infection status through an orthogonal filter.
The O-PLS-DA model was built by using an X-matrix containing all
spectral information and a binary dummy matrix, as Y-determining
class affiliation, for example infected or controls. Sevenfold cross-
validation was applied (Bro et al, 2008) to validate the models and
calculate the goodness of prediction Q2. To validate the statistical
power of the discriminatory metabolites, the P-values were calculated
for each data point using 10 000 permutations and back projected to
the O-PLS-DA plot, whereby regions that significantly differentiate
infected from non-infected animals at a level of Pp0.05 are coded in
red (Pitman, 1938).
For assessing the direct impact of the cerebral metabolic changes
caused by F. hepatica infection, a further development of the STOCSY
(Cloarec et al, 2005) and the statistical heterospectroscopy (Crockford
et al, 2006) method has been applied between two data matrices
whereby the selected regions occupied by each of the eight cerebral
biomarkers were integrated in MATLAB and represent the
Y-matrix. The spectral information of each other biological matrix
(e.g. biofluids and all other tissues) constituted the second matrix (X)
for calculating correlation structures between the spectral peaks and
the integrated metabolite information. To reduce the display complex-
ity and to avoid including artifacts and noise, spectral peaks were
picked by applying a threshold of 100 the s.d. calculated from the
first 500 data points, which consist of noise only. A 10 000-fold
permutation was embedded in the correlation script and only
correlations with Pp0.05 are displayed.
Cytokine multiplex quantification
Plasma from five F. hepatica-infected rats and five uninfected rats from
earlier NMR spectral preparation (e.g. 0.9% saline (NaCl) in
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D2O:H2O¼1:1), over six different time points, were tested by a
‘Mesoscale Multiplex Assay’ (MS6000 Rat Demonstration 7-Plex Ultra-
Sensitive kit, Meso Scale Discovery). The rat demonstration ‘7-Plex
Ultra-Sensitivity kit’ was used for this purpose, which includes IFN-g,
IL-1b, IL-4, IL-5, IL-13, KC/GRO, and TNF-a. Each samplewas assessed
using duplicates and split in 15ml per well in a 96-well plate. The
method was used according to the manufacturer’s specifications
(Meso Scale Discovery, Rat cytokine assays: Rat demonstration 7-Plex
Ultra-Sensitive kit), with the exception of the incubation time, which
was extended to 4 h to counteract the 1:1 dilution. An MSD Sector
imager was used to read the plates (Meso Scale Discovery, Sector
Imager 6000).
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (http://www.nature.com/msb).
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